Close Menu

Researchers are not so good at gauging whether a clinical trial will be successful, Stat News reports.

A team led by McGill University's Jonathan Kimmelman asked cancer researchers to predict whether certain clinical trials would make their primary endpoint, Stat News says, noting that the work isn't yet published. It adds that the cancer researchers queried tended to underestimate trials that would meet their endpoints.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.